Loading...
301408 logo

Anhui Huaren Health Pharmaceutical Co., Ltd.SZSE:301408 Stock Report

Market Cap CN¥6.3b
Share Price
CN¥15.79
n/a
1Y28.0%
7D-3.7%
Portfolio Value
View

Anhui Huaren Health Pharmaceutical Co., Ltd.

SZSE:301408 Stock Report

Market Cap: CN¥6.3b

Anhui Huaren Health Pharmaceutical (301408) Stock Overview

Anhui Huaren Health Pharmaceutical Co., Ltd. More details

301408 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends3/6

301408 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Anhui Huaren Health Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Anhui Huaren Health Pharmaceutical
Historical stock prices
Current Share PriceCN¥15.79
52 Week HighCN¥17.96
52 Week LowCN¥9.78
Beta0.45
1 Month Change5.27%
3 Month Change14.50%
1 Year Change27.96%
3 Year Changen/a
5 Year Changen/a
Change since IPO-37.61%

Recent News & Updates

Recent updates

Anhui Huaren Health Pharmaceutical (SZSE:301408) Takes On Some Risk With Its Use Of Debt

Feb 13
Anhui Huaren Health Pharmaceutical (SZSE:301408) Takes On Some Risk With Its Use Of Debt

Anhui Huaren Health Pharmaceutical (SZSE:301408) Is Reinvesting At Lower Rates Of Return

Dec 12
Anhui Huaren Health Pharmaceutical (SZSE:301408) Is Reinvesting At Lower Rates Of Return

These 4 Measures Indicate That Anhui Huaren Health Pharmaceutical (SZSE:301408) Is Using Debt Extensively

Aug 07
These 4 Measures Indicate That Anhui Huaren Health Pharmaceutical (SZSE:301408) Is Using Debt Extensively

Anhui Huaren Health Pharmaceutical's (SZSE:301408) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 07
Anhui Huaren Health Pharmaceutical's (SZSE:301408) Weak Earnings May Only Reveal A Part Of The Whole Picture

Returns On Capital Signal Tricky Times Ahead For Anhui Huaren Health Pharmaceutical (SZSE:301408)

Mar 25
Returns On Capital Signal Tricky Times Ahead For Anhui Huaren Health Pharmaceutical (SZSE:301408)

Shareholder Returns

301408CN Consumer RetailingCN Market
7D-3.7%5.8%1.6%
1Y28.0%8.6%16.0%

Return vs Industry: 301408 exceeded the CN Consumer Retailing industry which returned 8.5% over the past year.

Return vs Market: 301408 exceeded the CN Market which returned 16.5% over the past year.

Price Volatility

Is 301408's price volatile compared to industry and market?
301408 volatility
301408 Average Weekly Movement8.2%
Consumer Retailing Industry Average Movement6.3%
Market Average Movement5.3%
10% most volatile stocks in CN Market9.0%
10% least volatile stocks in CN Market3.0%

Stable Share Price: 301408's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 301408's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20017,930Jiale Hewww.hrjkjt.com

Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products.

Anhui Huaren Health Pharmaceutical Co., Ltd. Fundamentals Summary

How do Anhui Huaren Health Pharmaceutical's earnings and revenue compare to its market cap?
301408 fundamental statistics
Market capCN¥6.32b
Earnings (TTM)CN¥186.50m
Revenue (TTM)CN¥5.15b
33.9x
P/E Ratio
1.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301408 income statement (TTM)
RevenueCN¥5.15b
Cost of RevenueCN¥3.45b
Gross ProfitCN¥1.70b
Other ExpensesCN¥1.51b
EarningsCN¥186.50m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.47
Gross Margin33.00%
Net Profit Margin3.62%
Debt/Equity Ratio55.2%

How did 301408 perform over the long term?

See historical performance and comparison

Dividends

0.6%
Current Dividend Yield
22%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/10 03:36
End of Day Share Price 2025/12/10 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Anhui Huaren Health Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.